Korean J Hepatol.
2011 Sep;17(3):173-179. 10.3350/kjhep.2011.17.3.173.
The diagnosis and treatment of primary biliary cirrhosis
- Affiliations
-
- 1Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
- 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. jsh@snuhbh.org
- KMID: 1025195
- DOI: http://doi.org/10.3350/kjhep.2011.17.3.173
Abstract
- Primary biliary cirrhosis (PBC) is a slowly progressive cholestatic liver disease of autoimmune etiology. The initial presentation of PBC is various from asymptomatic, abnormal liver biochemical tests to overt cirrhosis. The diagnosis of PBC is based on cholestatic biochemical liver tests, presence of antimitochondrial antibody and histologic findings of nonsuppurative destructive cholangitis. Although the diagnosis is straightforward, it could be underdiagnosed because of its asymptomatic presentation, or underrecognition of the disease. UDCA in a dose of 13-15 mg/kg is the widely approved therapy which can improve the prognosis of patients with PBC. However, one-third of patients does not respond to UDCA therapy and may require liver transplantation. Every effort to diagnose PBC in earlier stage and to develop new therapeutic drugs and clinical trials should be made.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Prognosis of Korean patients with primary biliary cirrhosis
- Hepatocellular Carcinoma in Primary Biliary Cirrhosis: A Case Report
- A case of primary biliary cirrhosis in a male patient
- A Case of Diffuse Scleroderma Associated with Primary Biliary Cirrhosis and Isolated Pulmonary Hypertension
- A case of conventional antimitochondrial antibody test-negative primary biliary cirrhosis
